Dong Ruihua, Zhou Tong, Chen Jingsi, Zhang Meiru, Zhang Han, Wu Min, Li Shuguang, Zhang Liwen, Chen Bo
Key Laboratory of Public Health Safety of Ministry of Education, School of Public Health, Fudan University, Shanghai, 200032, China.
Gynecology and Obstetrics, Shanghai Fifth Hospital, Fudan University, Shanghai, 200240, China.
Arch Environ Contam Toxicol. 2017 Oct;73(3):431-441. doi: 10.1007/s00244-017-0441-6. Epub 2017 Aug 24.
Phthalate exposure has been reported to be associated with obesity (measured by body mass index [BMI]) and central obesity (measured by waist circumference [WC]). Yet, reported associations and the potential gender and age differences are inconsistent. We conducted a cross-sectional study involving 2330 participants in the fall of 2012. Urinary metabolites of ten phthalates were measured. Height, body weight, and waist circumference (WC) were measured using standardized methods. We performed logistic regression analyses to estimate the association between each urine phthalate metabolite (categorized into quartiles) and obesity and central obesity and conducted an additional, stratified analysis to explore the gender and age differences. In the overall study population, higher urinary levels of MMP, MEHHP, and MECPP were associated with increased ratios of central obesity. When stratifying by gender and central obesity, higher urinary levels of MMP, MEHHP, and MEOHP were associated with increased odds of central obesity in females, whereas MBP was significantly associated inversely with central obesity in females. In males, it showed no significant P value for trend (P trend). When stratifying by age in females, higher urinary levels of MEHP, MEOHP, MEHHP, and MECPP were associated with increased odds of central obesity in women aged ≤45 years. In females aged >45 years, it showed no significant P trend. In conclusion, we found that association between phthalates and central obesity was stronger than between phthalates and obesity; association between phthalates and central obesity was stronger in females than in males and was stronger in younger females (aged ≤45 years) than in older females (aged >45 years).
据报道,邻苯二甲酸盐暴露与肥胖(通过体重指数[BMI]衡量)和中心性肥胖(通过腰围[WC]衡量)有关。然而,已报道的关联以及潜在的性别和年龄差异并不一致。我们在2012年秋季进行了一项横断面研究,涉及2330名参与者。测量了十种邻苯二甲酸盐的尿液代谢物。使用标准化方法测量身高、体重和腰围(WC)。我们进行了逻辑回归分析,以估计每种尿液邻苯二甲酸盐代谢物(分为四分位数)与肥胖和中心性肥胖之间的关联,并进行了额外的分层分析,以探讨性别和年龄差异。在整个研究人群中,尿液中较高水平的MMP、MEHHP和MECPP与中心性肥胖比例增加有关。按性别和中心性肥胖分层时,尿液中较高水平的MMP、MEHHP和MEOHP与女性中心性肥胖几率增加有关,而MBP与女性中心性肥胖呈显著负相关。在男性中,趋势的P值无显著性(P趋势)。在女性中按年龄分层时,尿液中较高水平的MEHP、MEOHP、MEHHP和MECPP与45岁及以下女性中心性肥胖几率增加有关。在45岁以上的女性中,P趋势无显著性。总之,我们发现邻苯二甲酸盐与中心性肥胖之间的关联比邻苯二甲酸盐与肥胖之间的关联更强;邻苯二甲酸盐与中心性肥胖之间的关联在女性中比在男性中更强,在年轻女性(45岁及以下)中比在老年女性(45岁以上)中更强。